David Adkins
Physician Assistant · Spencer, WVNPI 1013976133
Payments from drug & device makers
Across 114 payments — averaging $17.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$777
- Pfizer$231
- Novartis$208
- Sanofi$130
- Astellas Pharma US Inc$106
- Merck$84
- plus $505 from 17 others
What the payments were for
- Food & beverage$1,95196%
- Education$904%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 50 | $777 |
| Pfizer | 12 | $231 |
| Novartis | 12 | $208 |
| Sanofi | 5 | $130 |
| Astellas Pharma US Inc | 2 | $106 |
| Merck | 5 | $84 |
| Johnson & Johnson | 4 | $63 |
| Verona Pharma, Inc. | 3 | $46 |
| Medtronic | 1 | $43 |
| Averitas Pharma Inc. | 2 | $42 |
| Harmony Biosciences LLC | 2 | $40 |
| Mylan Specialty L.p. | 3 | $38 |
| Boehringer Ingelheim | 2 | $30 |
| Lilly USA, LLC | 2 | $29 |
| Heartflow, Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| AstraZeneca | 1 | $22 |
| Viatris Specialty LLC | 1 | $20 |
| Abbott | 1 | $19 |
| Si-bone, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Dexcom, Inc. | 1 | $14 |
| Bioventus LLC | 1 | $13 |
How this compares
$2,041 in reported general payments places this provider in the 85th percentile of 833 physician assistant providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 85 | $101,342 |
| XareltoRivaroxaban | 79 | $82,284 |
| EntrestoSacubitril/Valsartan | 27 | $48,299 |
| BrilintaTicagrelor | 15 | $13,422 |
| Repatha SureclickEvolocumab | 16 | $12,605 |
| Ranolazine ErRanolazine | 82 | $4,962 |
| Metoprolol Succinate | 342 | $4,603 |
| Digoxin | 28 | $2,524 |
| Amiodarone Hcl | 58 | $1,268 |
| Potassium Chloride | 71 | $1,053 |
| Warfarin Sodium | 71 | $1,017 |
| Atorvastatin Calcium | 110 | $949 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 40 | $921 |
| Losartan Potassium | 115 | $899 |
| ClopidogrelClopidogrel Bisulfate | 79 | $856 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $231 | $101,34285 claims |
| Johnson & JohnsonXarelto | $63 | $82,28479 claims |
| NovartisEntresto | $208 | $48,29927 claims |
| AstraZenecaBrilinta | $22 | $13,42215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 833 physician assistant providers in West Virginia.
Other physician assistant in Spencer
- Amy ButtsWellsburg$258K
- Alexander EpperlySouth Charleston$21K
- Kelley WhoolerySouth Charleston$17K
- Jordan BrewerMorgantown$15K
- Tasha ElswickWinfield$14K
- Frances PauleyCharleston$14K
- Danielle MolinaCharleston$12K
- Erik AndersonSouth Charleston$11K
- Catherine EnsingerParkersburg$11K
- Gregory PorterSouth Charleston$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.